Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSwaminathan, Ashwinen
dc.contributor.authorMartin, Rhea Den
dc.contributor.authorGamon, Sandien
dc.contributor.authorAboltins, Craig Aen
dc.contributor.authorAthan, Eugeneen
dc.contributor.authorBraitberg, Georgeen
dc.contributor.authorCatton, Michael Gen
dc.contributor.authorCooley, Louiseen
dc.contributor.authorDwyer, Dominic Een
dc.contributor.authorEdmonds, Deidreen
dc.contributor.authorEisen, Damon Pen
dc.contributor.authorHosking, Kellyen
dc.contributor.authorHughes, Andrew Jen
dc.contributor.authorJohnson, Paul D Ren
dc.contributor.authorMaclean, Andrew Ven
dc.contributor.authorO'Reilly, Maryen
dc.contributor.authorPeters, S Ericaen
dc.contributor.authorStuart, Rhonda Len
dc.contributor.authorMoran, Rodneyen
dc.contributor.authorGrayson, M Lindsayen
dc.identifier.citationEmerging Infectious Diseases; 13(10): 1541-7en
dc.description.abstractFor pandemic influenza planning, realistic estimates of personal protective equipment (PPE) and antiviral medication required for hospital healthcare workers (HCWs) are vital. In this simulation study, a patient with suspected avian or pandemic influenza (API) sought treatment at 9 Australian hospital emergency departments where patient-staff interactions during the first 6 hours of hospitalization were observed. Based on World Health Organization definitions and guidelines, the mean number of "close contacts" of the API patient was 12.3 (range 6-17; 85% HCWs); mean "exposures" were 19.3 (range 15-26). Overall, 20-25 PPE sets were required per patient, with variable HCW compliance for wearing these items (93% N95 masks, 77% gowns, 83% gloves, and 73% eye protection). Up to 41% of HCW close contacts would have qualified for postexposure antiviral prophylaxis. These data indicate that many current national stockpiles of PPE and antiviral medication are likely inadequate for a pandemic.en
dc.subject.otherAntiviral Agents.therapeutic useen
dc.subject.otherGuideline Adherenceen
dc.subject.otherInfection Control.methods.standardsen
dc.subject.otherInfectious Disease Transmission, Patient-to-Professional.prevention & controlen
dc.subject.otherInfluenza A Virus, H5N1 Subtypeen
dc.subject.otherInfluenza, Human.drug therapy.prevention & controlen
dc.subject.otherPatient Simulationen
dc.subject.otherPersonnel, Hospitalen
dc.subject.otherProspective Studiesen
dc.subject.otherProtective Clothing.utilizationen
dc.subject.otherQuality Assurance, Health Careen
dc.titlePersonal protective equipment and antiviral drug use during hospitalization for suspected avian or pandemic influenza.en
dc.typeJournal Articleen
dc.identifier.journaltitleEmerging infectious diseasesen
dc.identifier.affiliationAustin Health, Heidelberg, Victoria, Australiaen
dc.type.austinJournal Articleen
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Jan 26, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.